Brainworks

The premier interdisciplinary rehabilitation solution since 2003! Brainworks focuses in client-centred rehabilitation services for individuals who have been seriously injured in motor vehicle collisions, and their families. Brainworks offers innovative treatment programs to individuals with brain injury, chronic pain, depression & sleep disturbances. We provide direct rehabilitation services north of Toronto to north of Sudbury, with consultation, education & eRehabilitation service capabilities throughout Ontario.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

FUTURE OF HEALTHCARE

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

news image

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More

HEALTH TECHNOLOGY

MICROBOT MEDICAL ANNOUNCES STRATEGIC COLLABORATION WITH STRYKER CORPORATION TO DEVELOP THE LIBERTY® ROBOTIC SYSTEM FOR NEUROVASCULAR APPLICATIONS

Microbot Medical | December 28, 2021

news image

Microbot Medical Inc.announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY Robotic System to develop the world’s first dedicated robotic procedural kits for use in certain neurovascular procedures. “We have already ensured that the L...

Read More

UCSF, FORTANIX, INTEL, AND MICROSOFT AZURE COLLABORATES TO ESTABLISH A CONFIDENTIAL COMPUTING PLATFORM TO ACCELERATE AI IN HEALTHCARE

UCSF | October 08, 2020

news image

UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure today have formed a collaboration to establish a confidential computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms. The platform will provide a “zero-trust” environment to protect both the intellectual property of an algorithm and the p...

Read More

INSURANCE

EXELA EXPANDS PCH GLOBAL SOLUTION WITH LEADING HEALTHCARE INSURER

Exela Technologies | January 12, 2022

news image

Exela Technologies, Inc. (“Exela”)today announced that it continues to expand its relationship with a leading health insurance organization that spans almost two decades. This customer continues to accelerate deployment of Exela’s PCH Global platform to speed up their digital transformation and improve both the member and provider experience. The latest expansion is valued at $6.2 million of additional contract value revenue. Exela continues to invest in expa...

Read More
news image

FUTURE OF HEALTHCARE

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More
news image

HEALTH TECHNOLOGY

MICROBOT MEDICAL ANNOUNCES STRATEGIC COLLABORATION WITH STRYKER CORPORATION TO DEVELOP THE LIBERTY® ROBOTIC SYSTEM FOR NEUROVASCULAR APPLICATIONS

Microbot Medical | December 28, 2021

Microbot Medical Inc.announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY Robotic System to develop the world’s first dedicated robotic procedural kits for use in certain neurovascular procedures. “We have already ensured that the L...

Read More
news image

UCSF, FORTANIX, INTEL, AND MICROSOFT AZURE COLLABORATES TO ESTABLISH A CONFIDENTIAL COMPUTING PLATFORM TO ACCELERATE AI IN HEALTHCARE

UCSF | October 08, 2020

UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure today have formed a collaboration to establish a confidential computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms. The platform will provide a “zero-trust” environment to protect both the intellectual property of an algorithm and the p...

Read More
news image

INSURANCE

EXELA EXPANDS PCH GLOBAL SOLUTION WITH LEADING HEALTHCARE INSURER

Exela Technologies | January 12, 2022

Exela Technologies, Inc. (“Exela”)today announced that it continues to expand its relationship with a leading health insurance organization that spans almost two decades. This customer continues to accelerate deployment of Exela’s PCH Global platform to speed up their digital transformation and improve both the member and provider experience. The latest expansion is valued at $6.2 million of additional contract value revenue. Exela continues to invest in expa...

Read More